Skip to content
healthcare.dev

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

NDC 69097-741, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, tablet, film coated, from Cipla USA Inc..

Product NDC
69097-741
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090958
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-741 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EMTRICITABINE200 mg/1
  • TENOFOVIR DISOPROXIL FUMARATE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Nucleosides [CS]

Package NDCNDC-11Package
69097-741-026909707410230 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-741-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d08c9455-e788-435c-9076-2bdb1a4f5b37

Use it

Look up 69097-741 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-741 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-741. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.